Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alpha ointment is a topical polyherbal formulation composed of *Lawsonia inermis* (henna) and *Curcuma longa* (turmeric/curcumin) extracts. It is primarily utilized in the management of burn wounds, radiation-induced dermatitis, and chemotherapy-induced hand-foot syndrome. The ointment exerts its therapeutic effects through anti-inflammatory, antioxidant, and antimicrobial activities, which collectively promote re-epithelialization, stimulate angiogenesis, and enhance granulation tissue formation. Clinical studies have demonstrated its efficacy in reducing pain, pruritus, and inflammation, often showing comparable or superior results to standard treatments like silver sulfadiazine and hydrocortisone in specific dermatological applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alpha ointment.